427 related articles for article (PubMed ID: 33808504)
21. Metalloproteinases and their inhibitors in tumor angiogenesis.
Handsley MM; Edwards DR
Int J Cancer; 2005 Jul; 115(6):849-60. PubMed ID: 15729716
[TBL] [Abstract][Full Text] [Related]
22. Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.
Georgiadis D; Yiotakis A
Bioorg Med Chem; 2008 Oct; 16(19):8781-94. PubMed ID: 18790648
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibodies against metzincin targets.
Santamaria S; de Groot R
Br J Pharmacol; 2019 Jan; 176(1):52-66. PubMed ID: 29488211
[TBL] [Abstract][Full Text] [Related]
24. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
Matsunaga Y; Koda M; Murawaki Y
Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313
[TBL] [Abstract][Full Text] [Related]
25. Aggravation of ADAMTS and matrix metalloproteinase production and role of ERK1/2 pathway in the interaction of osteoarthritic subchondral bone osteoblasts and articular cartilage chondrocytes -- possible pathogenic role in osteoarthritis.
Prasadam I; Crawford R; Xiao Y
J Rheumatol; 2012 Mar; 39(3):621-34. PubMed ID: 22247346
[TBL] [Abstract][Full Text] [Related]
26. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human fetal testis and ovary.
Robinson LL; Sznajder NA; Riley SC; Anderson RA
Mol Hum Reprod; 2001 Jul; 7(7):641-8. PubMed ID: 11420387
[TBL] [Abstract][Full Text] [Related]
27. Differential gene expression profiling of metalloproteinases and their inhibitors: a comparison between bovine intervertebral disc nucleus pulposus cells and articular chondrocytes.
Cui Y; Yu J; Urban JP; Young DA
Spine (Phila Pa 1976); 2010 May; 35(11):1101-8. PubMed ID: 20473119
[TBL] [Abstract][Full Text] [Related]
28. ADAMTS and ADAM metalloproteinases in osteoarthritis - looking beyond the 'usual suspects'.
Yang CY; Chanalaris A; Troeberg L
Osteoarthritis Cartilage; 2017 Jul; 25(7):1000-1009. PubMed ID: 28216310
[TBL] [Abstract][Full Text] [Related]
29. Differential regulation of metzincins in experimental chronic renal allograft rejection: potential markers and novel therapeutic targets.
Berthier CC; Lods N; Joosten SA; van Kooten C; Leppert D; Lindberg RL; Kappeler A; Raulf F; Sterchi EE; Lottaz D; Marti HP
Kidney Int; 2006 Jan; 69(2):358-68. PubMed ID: 16408127
[TBL] [Abstract][Full Text] [Related]
30. Roles of MMP/TIMP in regulating matrix swelling and cell migration during chick corneal development.
Huh MI; Lee YM; Seo SK; Kang BS; Chang Y; Lee YS; Fini ME; Kang SS; Jung JC
J Cell Biochem; 2007 Aug; 101(5):1222-37. PubMed ID: 17295208
[TBL] [Abstract][Full Text] [Related]
31. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
32. Variability in melanoma metalloproteinase expression profiling.
Giricz O; Lauer JL; Fields GB
J Biomol Tech; 2010 Dec; 21(4):194-204. PubMed ID: 21119930
[TBL] [Abstract][Full Text] [Related]
33. Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?
Rivera S; Khrestchatisky M; Kaczmarek L; Rosenberg GA; Jaworski DM
J Neurosci; 2010 Nov; 30(46):15337-57. PubMed ID: 21084591
[TBL] [Abstract][Full Text] [Related]
34. The roles of ADAMTS metalloproteinases in tumorigenesis and metastasis.
Wagstaff L; Kelwick R; Decock J; Edwards DR
Front Biosci (Landmark Ed); 2011 Jan; 16(5):1861-72. PubMed ID: 21196270
[TBL] [Abstract][Full Text] [Related]
35. Threonine 98, the pivotal residue of tissue inhibitor of metalloproteinases (TIMP)-1 in metalloproteinase recognition.
Lee MH; Rapti M; Knaüper V; Murphy G
J Biol Chem; 2004 Apr; 279(17):17562-9. PubMed ID: 14734567
[TBL] [Abstract][Full Text] [Related]
36. Key metalloproteinase-mediated pathways in the kidney.
Wozniak J; Floege J; Ostendorf T; Ludwig A
Nat Rev Nephrol; 2021 Aug; 17(8):513-527. PubMed ID: 33879883
[TBL] [Abstract][Full Text] [Related]
37. Expression of ADAMs (a disintegrin and metalloproteases) and TIMP-3 (tissue inhibitor of metalloproteinase-3) in human prostatic adenocarcinomas.
Karan D; Lin FC; Bryan M; Ringel J; Moniaux N; Lin MF; Batra SK
Int J Oncol; 2003 Nov; 23(5):1365-71. PubMed ID: 14532978
[TBL] [Abstract][Full Text] [Related]
38. Potential role of hyaluronic acid on bone in osteoarthritis: matrix metalloproteinases, aggrecanases, and RANKL expression are partially prevented by hyaluronic acid in interleukin 1-stimulated osteoblasts.
Mladenovic Z; Saurel AS; Berenbaum F; Jacques C
J Rheumatol; 2014 May; 41(5):945-54. PubMed ID: 24737908
[TBL] [Abstract][Full Text] [Related]
39. Extracellular metalloproteinases in neural crest development and craniofacial morphogenesis.
Christian L; Bahudhanapati H; Wei S
Crit Rev Biochem Mol Biol; 2013; 48(6):544-60. PubMed ID: 24066766
[TBL] [Abstract][Full Text] [Related]
40. Metalloproteinases: A parade of functions in matrix biology and an outlook for the future.
Apte SS; Parks WC
Matrix Biol; 2015; 44-46():1-6. PubMed ID: 25916966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
